Author: bharatkashyap6969
U.S. consumers’ inflation outlook hits two-year low, Fed rate cuts anticipated
[ad_1] NEW YORK – The New York Federal Reserve has released new data indicating a significant shift in U.S. consumers’ inflation expectations, which have fallen to their lowest point in two years. Today, the Fed reported that the one-year inflation forecast has dropped to 3%, a level not seen since January 2021. This marks a considerable decline from the peak observed in mid-2022. The Fed’s report also showed a decrease in the longer-term outlook, with expectations for three-year and five-year inflation also trending downwards. Consumers are predicting slower price increases in key areas such as food and rent. However, they ... Read more
Bajaj Auto buyback at 43% premium to last closing price
[ad_1] New Delhi, Jan 8 (IANS) The board of directors of Bajaj Auto (NS:) has approved a Rs 4,000 crore share buyback at a price of Rs 10,000 a share which is at a huge premium of 43 per cent to the last closing price.Bajaj Auto share closed at Rs 6,985 on Monday, up by 0.25 per cent. Bajaj Auto said under the buyback issue it will be buying 40 lakh shares via tender route, representing 1.41 per cent of Bajaj Auto’s outstanding shares. In terms of Regulation 5 (via) of the Buyback Regulations, the Board / Buyback committee may, ... Read more
PTC Therapeutics posts 35% revenue growth in 2023
[ad_1] SOUTH PLAINFIELD, N.J. – PTC Therapeutics, Inc. (NASDAQ: NASDAQ:), a biopharmaceutical company, reported a 35% year-over-year growth in unaudited total revenue for 2023, amounting to $946 million. The announcement came as part of a presentation at the 42nd Annual J.P. Morgan Healthcare Conference today, where the company discussed its financial and operational progress, as well as its research and development (R&D) pipeline. The company’s Duchenne muscular dystrophy (DMD) franchise was a significant contributor to its revenue growth, with Translarna™ (ataluren) and Emflaza® (deflazacort) generating unaudited revenues of $355 million and $255 million respectively. The growth was attributed to an ... Read more
Income inequality declining in India, says SBI report
[ad_1] New Delhi, Jan 8 (IANS) Individual income inequality in the country has significantly declined during FY2014-22 with 36.3 per cent of taxpayers moving up from lower income to the higher income tax bucket, resulting in a 21.3 per cent additional income, according to an SBI (NS:) report.The SBI Research Department has, for the first time in the Indian context, used publicly available income tax data to measure the estimates of inequality. According to the recent data, the ITRs filed by individual taxpayers earning between Rs 5 lakh and Rs 10 lakh climbed by 295 per cent in the assessment ... Read more
Sony planning to call off the merger pact with Zee
[ad_1] New Delhi, Jan 8 (IANS) Sony Group Corp is planning to call off the merger pact of its India unit with Zee Entertainment (NS:) Enterprises, capping two years of drama and delay in creating a $10 billion media giant, said people familiar with the matter, as per media reports.The Japanese conglomerate is looking to cancel the deal due to a standoff over whether Zee’s Chief Executive Officer Punit Goenka, also its founder’s son, would lead the merged entity, the people said, asking not to be named as the information is not public, Bloomberg reported. While the agreement signed in ... Read more
India shares lower at close of trade; Nifty 50 down 0.91%
[ad_1] Investing.com – India equities were lower at the close on Monday, as losses in the , and sectors propelled shares lower. At the close in NSE, the lost 0.91%, while the index declined 0.93%. The biggest gainers of the session on the were Adani Ports and Special Economic Zone Ltd (NS:), which rose 1.60% or 18.45 points to trade at 1,172.70 at the close. Oil And Natural Gas Corporation Ltd (NS:) added 0.55% or 1.20 points to end at 217.65 and Sun Pharmaceutical Industries Ltd. (NS:) was up 0.52% or 6.80 points to 1,307.00 in late trade. Biggest losers ... Read more
FMCG stocks lead market lower
[ad_1] New Delhi, Jan 8 (IANS) The year-end rally which took the up by around 14 per cent from the 2023 October lows, is slowly running out of steam, says V.K. Vijayakumar, Chief Investment Strategist, Geojit Financial Services.The major challenge for the rally comes from the US market which is showing signs of weakness. The concern in the US now is that the market expectation of a rate cut in March may not materialise since the labour market continues to be tight and the unemployment data is lower than expected. Inflation coming under control means that the rate hiking cycle ... Read more
Samsung unveils new AI-based QLED TV at CES 2024
[ad_1] Las Vegas, Jan 8 (IANS) Samsung Electronics (KS:) on Monday unveiled a new high-end TV with more enhanced connectivity and features powered by its latest artificial intelligence (AI) processor, ahead of CES 2024.The flagship 2024 Neo QLED 8K TV incorporating the NQ8 AI Gen 3 AI processor, the company’s AI-based neural quantum processor technologies, premiered at a showcase named “The First Look” held in Las Vegas before this year’s annual tech show this week. Samsung Electronics said the model is the culmination of its 18 years of technology and know-how as a leader in the global TV market, reports ... Read more
Exact Sciences projects 17% Q4 revenue growth
[ad_1] MADISON, Wis. – Exact Sciences Corp. (NASDAQ:), a prominent cancer diagnostics company, expects to report a 17% increase in revenue for the fourth quarter of 2023 compared to the same period in the previous year. The anticipated revenue is projected to be between $645.5 million and $647.5 million, with Screening and Precision Oncology as significant contributors. The company’s Screening revenue, which includes services like the Cologuard test, is estimated to be between $486.0 million and $487.0 million, marking a 21% increase. Precision Oncology revenue is expected to be between $159.5 million and $160.5 million, up by 12%. Excluding COVID-19 ... Read more
Asian stocks slip as rate-cut bets ease; Inflation data deluge on tap
[ad_1] Investing.com– Most Asian stocks fell on Monday after a surprise jump in U.S. nonfarm payrolls saw markets rethink expectations for early interest rate cuts, with focus now turning to a string of key inflation readings this week. Regional stocks took a weak lead-in from Wall Street after higher-than-expected data for December spurred further trimming in bets that the Federal Reserve will cut interest rates by as soon as March 2024. Anticipation of the fourth-quarter earnings season also kept traders on edge. U.S. stock futures were largely flat in Asian trade on Monday. Regional trading volumes were somewhat dulled by ... Read more